Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus glycoproteins (GP) play a key role in targeting viral structural components to the budding compartments in the ER-Golgi intermediate compartment (ERGIC) and Golgi complex. However, the role of SFTSV GP in targeting structural proteins to the ERGIC and Golgi complex remains unresolved. In this study, we show that SFTSV GP plays a significant role in targeting RNA-dependent RNA polymerase (L) and nucleocapsid protein (NP) to the budding sites. Confocal microscopy was used to investigate the subcellular localization of SFTSV structural proteins. In SFTSV-infected cells, GP and L localized to the ER, ERGIC and Golgi complex, whereas NP localized to the ERGIC and Golgi complex. In addition, GP colocalized with L and NP in infected cells. In cells singly transfected with GP, L or NP, GP localized to the same subcellular compartments as in infected cells. However, L or NP alone did not localize to the ER, ERGIC, or Golgi complex. Cotransfection experiments showed that GP altered the localization of L to the ERGIC and Golgi complex but not that of NP. Interestingly, plasmid-expressed NP fused with a hemagglutinin tag localized to the ERGIC and Golgi complex when expressed in SFTSV-infected cells and colocalised with GP, suggesting that GP plays a role in the subcellular localization of L and NP in infected cells. Thus, the SFTSV structural components start to assemble at the ERGIC to Golgi complex. GP is required for transporting L and NP to the ERGIC and Golgi complex. In addition, targeting of NP requires interaction with other factors besides GP.
Severe fever with thrombocytopenia syndrome (SFTS), a febrile disease in humans, is characterized by severe fever, diarrhea, vomiting, leucopenia, thrombocytopenia, elevated liver enzymes, and multiple organ failure (8). The majority of patients with SFTS have been identified in rural regions of China; however, SFTS cases and deaths due to the disease have also been reported in Japan and South Korea. The SFTS virus (SFTSV) was first isolated in 2009 from the blood of a Chinese patient with SFTS (34) . SFTSV is transmitted through the bite of an infected tick; tick vectors for SFTSV include Hemaphysalis longicornis and Amblyoma testidunarium (32, 36) . Case fatality rates due to SFTS vary among the three same intracellular compartment. In the Phenuiviridae family, GP plays an important role in targeting other structural components to the sites of virus assembly and maturation. Immunocytochemical and electron microscopy studies have shown that UUKV, Bunyamwera virus (BUNV), RVFV, and hantavirus GP accumulate in the pre-Golgi and Golgi complex (3, 6, 7, 14, 16, 18, 20, 22) . However, it remains to be determined which cellular compartments are involved in the maturation of SFTSV. The accumulation of GP in the ERGIC and Golgi complex plays a central role in driving the formation of progeny virus. The NP and L proteins of RVFV (4, 18) and UUKV (15) traffic through the secretory pathway via interactions with GP. It remains unknown how the NP and L proteins of SFTSV are recruited to the ERGIC and Golgi complex for virus assembly. Revealing the basic steps in the lifecycle of SFTSV could provide the necessary information needed to develop specific inhibitors for SFTSV. The high biosafety containment requirement for handling SFTSV has delayed progress in this area of research. Therefore, the use of plasmid vectors for the expression of SFTSV proteins is a convenient way to circumvent the requirement for conducting experiments in high biosafety containment facilities. In this study, we used fluorescence microscopy to examine the subcellular localization of SFTSV structural proteins in cells infected with SFTSV and in cells expressing recombinant proteins. Our results suggest that GP is required for targeting L to the ERGIC and Golgi complex. However, the targeting of NP requires interaction with other factors besides GP.
MATERIALS AND METHODS
Cells. Vero E6 cells were maintained in minimum essential medium (Gibco, Thermo Fisher Scientific Inc., Waltham, MA, USA) supplemented with 5% fetal bovine serum (Biowest, Riverside, MO, USA) and penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO, USA). Human embryonic kidney 293T cells were grown in high-glucose Dulbecco's modified eagle medium (Gibco, Thermo Fisher Scientific Inc.) supplemented with 10% fetal bovine serum and penicillin/streptomycin. Cells were cultured at 37°C in 5% CO 2 .
Viral infection. The SFTSV YG1 strain used for all virus infection studies was a generous gift from Dr. Ken Maeda, Yamaguchi University (13, 26). For indirect immunofluorescence assays, Vero E6 cells were grown on 24-well 4-mm HTC glass slides (Thermo countries with reported cases. The reported case fatality rates range from ~12% in China (5,10), to ~12-30% in Japan (8), to as high as 47% in South Korea (24). Although ribavirin and T-705 (favipiravir) exhibit inhibitory effects on SFTSV production, there are still no specific antiviral drugs available to treat SFTS (23, 27). Owing to the lack of specific antiviral treatments and to the severity of the disease caused by SFTSV and other recently discovered tickborne phleboviruses, such as Heartland virus (11), it is imperative to understand the lifecycle of SFTSV. Such knowledge will be useful for developing antivirals against SFTSV and other pathogenic phleboviruses. Until recently, the SFTSV was considered a member of the Bunyaviridae family, genus Phlebovirus (1, 33, 35) . Following a recent proposal to the International Committee on the Taxonomy of Viruses, the Bunyaviridae family was reclassified as the Bunyavirales order, and SFTSV now belongs to the Phenuiviridae family (1). The SFTSV genome consists of three single stranded negative-sense RNA segments. The large, medium, and small segments encode RNA-dependent RNA polymerase (L), glycoproteins (GP) Gn and Gc, and the nucleocapsid (NP) and non-structural (NSs) proteins, respectively. Viruses of the Phenuiviridae family replicate their genome in the cytoplasm of infected cells, and assemble and bud into the Golgi complex (14, 21). After entry into cells, the viral components are released into the cytoplasm where transcription and replication of the viral genome occur. Similar to strategies of other phleboviruses, SFTSV entry into host cells is mediated by Gn. Previous studies have shown that SFTSV Gn is responsible for trafficking Gc to the Golgi complex for virion assembly via a signal peptide present in Gn (19). The NP and L proteins of Rift Valley fever virus (RVFV), Uukuniemi virus (UUKV), and presumably SFTSV lack signal peptides, and are translated on cytoplasmic ribosomes (7, 18, 19). Phlebovirus GP is synthesized in the endoplasmic reticulum (ER) and then trafficked through the secretory pathway. Trafficking of viral components through the secretory pathway is necessary for the formation of progeny virus. It is generally known that the Phenuiviridae family viruses bud at the membranes of the Golgi complex. Recently, however, the ER-Golgi intermediate compartment (ERGIC) has also been proposed to be a site of virion assembly for other viruses in the Bunyavirales order such as UUKV (7), hantaviruses (20), and RVFV (4). For virus assembly to occur, viral structural components, as well as the genome, should be targeted to the Western blot analysis. Vero E6 cells infected with SFTSV and 293T cells transfected with pCSFTSV-GP, pCSFTSV-NP or pCSFTSV-L were rinsed once with PBS followed by lysis in a lysis buffer containing 25 mM Tris-HCl, pH 8.0; 150 mM NaCl; 1 mM ethylenediaminetetraacetic acid; 1% nonidet P-40; 1 mM dithiothreitol, and 5% glycerol. The samples were subjected to Western blot analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed, followed by transfer of proteins to a 0.45-μm pore immunoblot polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA). Membranes were blocked for 1 h at room temperature with Blockace (Dai Nippon, Osaka, Japan) followed by incubation with viral protein specific primary antibodies; the mouse anti-Gn monoclonal antibody (#6G6) was a gift from Dr. K. Yamada (Oita University, Japan), rabbit anti-NP polyclonal antibody raised against a 15-amino acid synthetic peptide (40-54) region of NP (Sigma Aldrich Japan, Custom products, Japan), or rabbit anti-L peptide polyclonal antibody raised against a 15-amino acid synthetic peptide (386-400) region of L (Frontier Institute Co., ltd, Japan). Horseradish peroxidase-conjugated anti-mouse/anti-rabbit IgG were used as secondary antibody and incubated with the membrane for 1 h. After each incubation step, the membrane was washed three times with an appropriate volume of PBS for 5 min. The signals were developed by ECL reagents (Amersham, GE Healthcare Life Sciences, Piscataway, NJ, USA).
Indirect immunofluorescence assay. Cells were labeled with rabbit anti-Gn or Gc polyclonal antibody (#6647 or #6653; ProSci Inc., CA, USA) as described by Tsuda et al. (29), anti-NP, or anti-L antibody. The ER marker protein disulfide isomerase, PDI mouse monoclonal antibody (Enzo Life Sciences, Farmingdale, NY, USA), anti-ERGIC-53 mouse monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and Golgi marker Alexa Fluor 594-conjugated wheat germ agglutinin (WGA; Thermo Fisher Scientific Inc.) were used to label the organelles. Alexa Fluor 488/594 anti-rabbit/anti-mouse antibodies (Thermo Fisher Scientific Inc.) were used as secondary antibodies, respectively. The slides were mounted with ProLong™ Gold antifade reagent (Thermo Fisher Scientific Inc.) according to the manufacturer's instructions. Fluorescence images were acquired using a Zeiss LSM 700 confocal laser scanning microscope (Zeiss, Urbana, IL, USA) with a 63× oil lens.
Fisher Scientific Inc.). The cells were inoculated with virus at a multiplicity of infection of 0.02. After incubation for 72 hours (h), cells were fixed with 10% neutral buffered formalin (Nacalai, Kyoto, Japan) and permeabilized with 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 5 min at room temperature. All virus work was performed in biosafety level 3 conditions following governmental and institutional guidelines.
Plasmid construction.
The full open reading frames (ORFs) of SFTSV NP, GP, and L were cloned into the pCAGGS-MCS mammalian expression vector. Cloning primers for NP, GP and L were designed based on the Genbank sequence with accession numbers AB817995, AB817987 and AB817979, respectively. The plasmids were generated using standard molecular cloning techniques and confirmed by sequencing. Briefly, complementary DNA (cDNA) was synthesized by polymerase chain reaction (PCR) from RNA extracted from cells infected with the SFTSV YG1 strain. The ORFs of NP and GP from the cDNA were amplified with primers flanked by EcoRI and BglII sites and cloned into the pCAGGs-MCS plasmid vector. The resultant plasmids were designated pCSFTSV-GP (29) and pCSFTSV-NP, containing the ORFs of GP and NP, respectively. Epitope-tagged NP was similarly constructed using primers containing the hemagglutinin (HA) tag sequence. Three fragments of the ORF coding for L protein-SFTSV L-I (17-1749), SFTSV L-II (1591-5261), and SFTSV L-III (5135-6271)-were amplified from cDNA with primers flanked by ClaI/ BamHI, BamHI/SpeI, and SpeI/KpnI endonuclease recognition sites, respectively, and cloned into the aforementioned sites of the pATX vector. Each fragment was then digested with the appropriate enzymes and ligated to generate the full coding sequence of L. The entire coding sequence of L was then inserted into the ClaI and KpnI sites of the pCAGGS-MCS vector to generate the L expression plasmid pCSFTSV-L. The plasmid sequence was confirmed by Sanger sequencing prior to use.
Expression of recombinant proteins. Vero E6 cells were transfected with either single or combinations of expression plasmids; pCSFTSV-GP, pCSFTSV-NP, or pCSFTSV-L by lipofection using 3 μL TransIT LT1/μg DNA (Mirus Bio LLC, Madison, WI, USA) according to the manufacturer's protocol. The cells were incubated at 37°C for 24 h and fixed for immunofluorescence assays as described above.
The subcellular localization of SFTSV structural proteins in transfected cells
We transfected Vero E6 cells with either pCSFTSV-GP, pCSFTSV-NP, or pCSFTSV-L to assess whether GP, NP, and L could localize to the same intracellular compartments when the proteins were expressed singly. The subcellular localization of the SFTSV structural proteins was investigated in Vero E6 cells at 24 h post-transfection (hpt). Singly-expressed GP colocalized with the ER, ERGIC, and Golgi markers (Fig. 3A) . The subcellular localization of NP and L differed from that observed in infected cells shown in Fig. 2 ; NP and L did not localize to the ER, ERGIC, and Golgi complex (Fig. 3B and 3C) . These results indicate that of the three SFTSV structural proteins, only GP localizes to the ER, ERGIC, and Golgi complex in the absence of other SFTSV components. In contrast, NP and L appeared to require other viral components for their ER, ERGIC, and Golgi complex localization.
GP is required for the recruitment of L to the ERGIC and Golgi complex
The GP of phenuiviruses is important for targeting other viral structural proteins to the sites of assembly. First we evaluated the intracellular localization of GP with NP or L in infected Vero E6 cells (Fig. 4A ). GP colocalized with NP and L in perinuclear compartments in infected cells. To investigate the role of GP in the subcellular localization of L, Vero E6 cells were cotransfected with pCSFTSV-L and pCSFTSV-GP expressing L and GP, respectively. L partially colocalized with GP in transfected cells (Fig. 4C) . To further characterize the relationship between GP and L, we assessed the localization of L to the ERGIC and Golgi complex in cells that coexpressed GP and L. In the presence of GP, L was detected in the ERGIC and Golgi complex (Fig. 4C) . These results showed that GP facilitates the localization of L to the budding compartments. Conversely, in cells that co-expressed NP and GP, NP did not colocalize with GP (Fig. 4B) . NP accumulated in the cytoplasm and was not detected in the ERGIC and Golgi complex. We further investigated whether the localization of NP could be altered in the presence of GP with L, or NSs. In cells co-expressing NP and GP with L or NSs, NP did not colocalize with GP (data not shown). In addition, we observed no colocalization between NP and NSs ( Supplementary  Fig.) . Furthermore, NP did not localize to the budding compartments in cells coexpressing NP and GP with either L or NSs. These results suggest that another virus factor except the known viral proteins
RESULTS

Detection system of SFTSV structural proteins
Viruses of the Phenuiviridae family use host cell intracellular compartments for the production of progeny virions. To understand the basic steps in the lifecycle of SFTSV, we focused on the intracellular kinetics of virus structural proteins. We constructed the mammalian expression plasmids, pCSFTSV-GP, pCSFTSV-NP, or pCSFTSV-L, encoding GP, NP or L respectively. The ORF of each structural protein was inserted into the multi-cloning site of the mammalian expression vector (pCAGGS), and protein expression was confirmed by immunofluorescence staining and Western blot analysis using specific antibodies against the viral proteins. Fig. 1A shows that our antibodies specifically detected the expressed proteins; GP, NP and L in the cytoplasm. Both Gn and Gc showed similar expression pattern in GP expressing cells (data not shown), therefore, throughout this paper only the term GP will be used to denote both Gn and Gc. The correct molecular weights of expressed proteins were confirmed by Western blot analysis (Fig. 1B) . The expression of L protein was much lower in infected cells compared to the plasmid expressing cells. Each protein expressed by the plasmids was the same size as viral protein detected in infected cells. These results indicate that our protein expression and detection system are useful tools for analysis of viral protein dynamics in cells.
The subcellular localization of SFTSV structural proteins in infected cells
To determine the sites of formation of SFTSV particles, we first investigated whether SFTSV structural proteins could be detected in pre-Golgi-namely the ER and ERGIC-as well as Golgi complex. We performed a detailed analysis of the colocalization of SFTSV structural proteins with specific compartment markers. Vero E6 cells infected with SFTSV were fixed at 72 h post-infection (hpi) and stained with organelle markers and antibodies to viral structural proteins (Fig. 2) . Colocalization experiments revealed that GP and L protein fluorescent signals colocalized with those of the ER, ERGIC, and Golgi markers ( Fig. 2A and 2C) . In contrast, a low degree of colocalization was observed between NP and the ER marker; NP mainly localized to the ERGIC and the Golgi complex (Fig. 2B) . These results suggested that SFTSV structural proteins start to assemble in the ERGIC as previously shown in hantavirus virion assembly (20).
taining NP fused with HA tag (pCSFTSV-HA-NP). The cells were then infected or mock-infected with SFTSV and analyzed by indirect immunofluorescence assay to assess whether the epitope-tagged NP could be detected in the ERGIC and Golgi complex. In infected cells, HA-NP colocalized with GP (Fig. 5) . Furthermore, HA-NP was detected in the ERGIC and Golgi complex in SFTSV-infected cells. HA-NP are required for the ERGIC and Golgi complex localization of NP.
Localization of NP to the ERGIC and Golgi complex
To determine whether other components of SFTSV are associated with localizing NP to the ERGIC and Golgi, we transfected Vero cells with plasmids con- volved in the production of infectious viral particles (2, 7, 14, 18-20, 22). Herein, we found that SFTSV structural proteins, like those of other representative members of the Bunyavirales order, localized to the ERGIC and Golgi complex in infected cells (Fig. 2) . This result suggested that virion assembly of SFTSV starts in compartments such as the ERGIC that lie before the Golgi complex. This data supports previous reports on the targeting of NP and L to the ERGIC prior to movement to the Golgi complex (7, 20) . Elucidating the subcellular localization of SFTSV structural proteins is important for understanding the steps in the lifecycle of SFTSV. We used recombinant proteins to express the SFTSV structural proteins in cells singly transfected with plasmids and elucidated the subcellular distribution of GP, NP, and L proteins. GP was detected mainly in the ERGIC, and Golgi complex in cells that singly expressed GP in a manner similar to GP localization in SFTSV-infected cells (Fig. 3) . Our findings support previous studies that showed SFTSV GP accumulation in intracellular compartments such as the ER and Golgi complex (19, 28). In contrast, NP and L proteins did not independently localize to the ERGIC and Golgi complex, indicating that additional viral factors are was not detected in the ERGIC and Golgi complex in mock-infected cells, similar to results shown in Fig. 3B when NP lacking the HA tag was expressed. These results indicated that the proteins expressed using the pCAGGS vector could correctly localize to the subcellular compartments in a manner comparable to the SFTSV-expressed viral proteins in infected cells. This result also indicates that other viral components may play a role in targeting NP to the ERGIC and Golgi complex.
DISCUSSION
Negative strand RNA viruses use the host cell secretory pathway for the production of infectious virus particles (17, 19). Panda et al. used RNA interference screening of host proteins to show that lymphocytic choriomeningitis virus, human parainfluenza virus type 3, and vesicular stomatitis virus require the host cell secretory pathway for infection (17). It is generally accepted that viruses of the Bunyavirales order assemble and bud into the Golgi complex (14, 21). Recently, not only the Golgi complex but the ERGIC has also been proposed as a site for virion assembly. The localization of viral structural proteins to the ERGIC and Golgi complex is in- due to loss of function in our plasmid expression system; but that NP colocalization with GP likely requires other viral factors besides GP, L, or NSs. Piper et al. reported that genomic RNA is required for RVFV packaging into virions (18). Whether this is the case with SFTSV requires further investigation. We are currently conducting experiments to determine the other viral factors required for NP localization to the budding compartments. Budding of virions of RVFV (4) and BUNV (21) takes place at the Golgi complex. Pre-Golgi compartments are also sites for virion budding for UUKV (7). In hantavirus (20) budding of virions may start at the ERGIC and continue to the Golgi complex. The ERGIC-53 protein binds GP of several viruses including hantaviruses, arenaviruses, and coronaviruses (9, 12, 30). In addition, binding of virus to ERGIC-53 is required for the production of infectious virus particles of filovirus, arenavirus, and coronavirus (9). The Golgi complex is known as a site for virus budding in the Bunyavirales order. Plegge et al. reported that trafficking of SFTSV GP to the Golgi complex is facilitated by Gn and that interaction of Gn with Gc is required for the production of infectious virus particles (19). Further studies are required to clarify the role of the ERGIC and Golgi complex in virion assembly and maturation during the production of SFTSV particles. Our study showed that SFTSV structural proteins are targeted to the ERGIC and Golgi complex during the lifecycle of the virus. GP of SFTSV play an important role in the localization of structural proteins to the budding site, ERGIC and Golgi complex. In addition to GP, NP may require other viral factors for trafficking through the secretory pathway.
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